杭州标准是否适用于西方国家肝细胞癌肝移植患者？ - Suppr

Suppr

超能文献

Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries?

作者信息

Audet Maxime, Panaro Fabrizio, Piardi Tullio, Wolf Philippe

出版信息

Liver Transpl. 2009 Jul;15(7):822-3; author reply 824-6. doi: 10.1002/lt.21765.

DOI:10.1002/lt.21765

PMID:19562722

Abstract

摘要

相似文献

Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries?

Liver Transpl. 2009 Jul;15(7):822-3; author reply 824-6. doi: 10.1002/lt.21765.

Selection criteria for patients with hepatocellular carcinoma in liver transplantation.

Transplantation. 2009 Aug 15;88(3):442-3; author reply 443. doi: 10.1097/TP.0b013e3181af385a.

Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation.

Eur J Radiol. 2010 Jun;74(3):e6-e11. doi: 10.1016/j.ejrad.2009.03.012. Epub 2009 Apr 3.

Is tumor biopsy necessary?

Liver Transpl. 2011 Oct;17 Suppl 2:S14-25. doi: 10.1002/lt.22374.

Liver transplantation for hepatocellular carcinoma: the best treatment, but for which patient?

Hepatology. 1996 Dec;24(6):1539-41. doi: 10.1002/hep.510240640.

Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma.

Liver Transpl. 2008 Oct;14(10):1449-60. doi: 10.1002/lt.21576.

Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.

Liver Transpl. 2009 Sep;15(9):1003-6. doi: 10.1002/lt.21840.

The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.

Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.

[Hepatocellular cancer with a background of liver cirrhosis].

Klin Med (Mosk). 1996;74(2):2-5.

Liver transplantation for hepatocellular carcinoma: how far can we push the envelope?

Singapore Med J. 2003 Jun;44(6):309-11.

引用本文的文献

Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study.

Ann Transplant. 2019 Aug 20;24:489-498. doi: 10.12659/AOT.917296.

Hepatitis B and hepatocellular carcinoma recurrence after living donor liver transplantation: The role of the Milan criteria.

Turk J Gastroenterol. 2019 Jan;30(1):75-80. doi: 10.5152/tjg.2018.18794.

Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany.

Langenbecks Arch Surg. 2018 Aug;403(5):643-654. doi: 10.1007/s00423-018-1696-8. Epub 2018 Aug 17.

Advances in predicting the prognosis of hepatocellular carcinoma recipients after liver transplantation.

J Zhejiang Univ Sci B. 2018 Jul;19(7):497-504. doi: 10.1631/jzus.B1700156.

The stratifying value of Hangzhou criteria in liver transplantation for hepatocellular carcinoma.

PLoS One. 2014 Mar 27;9(3):e93128. doi: 10.1371/journal.pone.0093128. eCollection 2014.

Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: retrospective study of the Milan and Hangzhou criteria.

PLoS One. 2014 Jan 27;9(1):e87222. doi: 10.1371/journal.pone.0087222. eCollection 2014.

Current opinion on the role of resection and liver transplantation for hepatocellular cancer.

Indian J Gastroenterol. 2012 Jun;31(3):89-99. doi: 10.1007/s12664-012-0200-6. Epub 2012 Jun 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验